Cittadini et al. conducted a randomized, single-blinded, controlled trial on 158 patients with CHF (NYHA II-IV) and found significant improvement in exercise capacity, QoL and LV structure and function in patients receiving GH replacement [154]. Here, GH1 is linked to congestive heart failure.